AB Science S.A.

    Last Updated: Oct 18, 2021 3:29 p.m. EDT Delayed quote

    $ 14.98

    -0.02 -0.13%
    Previous Close
    Advanced Charting
    Volume: 507 65 Day Avg: 481.2
    105% vs Avg
    14.98 Day Range 14.98
    8.65 52 Week Range 26.70

    Your Watchlists

    Customize eLesor

    Have Watchlists? Log in to see them here or sign up to get started.

    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    ABSCF Overview


    5 Day
    • -0.13%
    1 Month
    • -6.20%
    3 Month
    • -19.68%
    • -36.23%
    1 Year
    • 26.09%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 1 Full Ratings

    Recent News

    No Headlines Available

    H.C. Wainwright Sticks to Their Buy Rating for AB Science SA (ABSCF)

    on SmarterAnalyst

    AB Science S.A.

    AB Science SA engages in the research, development, and sales of protein kinase inhibitor drugs. It develops pharmaceutical products for the treatment of cancer, neurological, and inflammatory diseases. The firm also engages in the field of veterinary medicine. The company was founded by Alain Moussy and Jean-Pierre Kinet on July 11, 2001 and is headquartered in Paris, France.